Replimune Group (REPL) Stock: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$11.99
0.27 (2.30%)
â˛
5d:
+2.04%
30d:
-7.48%
90d:
+14.63%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 19, 2026 at $11.05 · last confirmed Oct 21, 2026
Strength: 6.7/10
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: REPL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: REPL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $11.99, which is considered slightly low relative to its 30-day fair value range of $11.88 to $13.36.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $10.67, while resistance sits at $13.56.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.50 (+62.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $10.67, while resistance sits at $13.56.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.50 (+62.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$11.88 -
$13.36
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding REPL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 62.6% below Wall St target ($19.50)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.88 -
$13.36
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$10.67
Resistance Level
$13.56
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.75
Wall Street Target
$19.50
(+62.6%)
Share & Embed Analysis
Last updated: October 22, 2026 5:35 PM ET
Data refreshes hourly during market hours. Next update: 6:35 PM
Data refreshes hourly during market hours. Next update: 6:35 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 61 BUY |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$686 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 66 BUY |
|
CGON
CG Oncology, Inc. CommonâĻ |
STRONG BUY
15 analysts |
$91 | 64 BUY |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
